ZNF425

gene
On this page

Summary

ZNF425 (zinc finger protein 425, HGNC:20690) is a protein-coding gene on chromosome 7q36.1, encoding Zinc finger protein 425 (Q6IV72). Acts as a transcriptional repressor.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in negative regulation of DNA-templated transcription. Located in cytoplasm and nucleoplasm.

Source: NCBI Gene 155054 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 105 total
  • MANE Select transcript: NM_001001661

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20690
Approved symbolZNF425
Namezinc finger protein 425
Location7q36.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000204947
Ensembl biotypeprotein_coding
OMIM619507
Entrez155054

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 4 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000378061, ENST00000483014, ENST00000484196, ENST00000495685, ENST00000926832, ENST00000951283

RefSeq mRNA: 1 — MANE Select: NM_001001661 NM_001001661

CCDS: CCDS34773

Canonical transcript exons

ENST00000378061 — 4 exons

ExonStartEnd
ENSE00001476104149112137149112295
ENSE00001476105149118222149118348
ENSE00001476106149126196149126324
ENSE00001944997149102784149105566

Expression profiles

Bgee: expression breadth ubiquitous, 159 present calls, max score 77.81.

FANTOM5 (CAGE): breadth broad, TPM avg 1.0429 / max 15.1707, expressed in 638 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
867281.0429638

Top tissues by expression

246 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047377.81gold quality
secondary oocyteCL:000065573.66silver quality
skeletal muscle tissue of rectus abdominisUBERON:000451173.59gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099173.42gold quality
ventricular zoneUBERON:000305373.14gold quality
ganglionic eminenceUBERON:000402373.14gold quality
stromal cell of endometriumCL:000225573.04gold quality
cortical plateUBERON:000534372.96gold quality
prefrontal cortexUBERON:000045172.41gold quality
lower esophagus mucosaUBERON:003583470.77gold quality
gastrocnemiusUBERON:000138870.66gold quality
muscle of legUBERON:000138370.52gold quality
Brodmann (1909) area 9UBERON:001354070.00gold quality
right frontal lobeUBERON:000281069.75gold quality
cerebellar hemisphereUBERON:000224569.08gold quality
cerebellar cortexUBERON:000212969.07gold quality
right hemisphere of cerebellumUBERON:001489068.90gold quality
hindlimb stylopod muscleUBERON:000425268.59gold quality
anterior cingulate cortexUBERON:000983568.59gold quality
smooth muscle tissueUBERON:000113568.00gold quality
muscle tissueUBERON:000238567.83gold quality
cerebellumUBERON:000203767.79gold quality
lower esophagusUBERON:001347367.71gold quality
skeletal muscle tissueUBERON:000113467.68gold quality
frontal cortexUBERON:000187067.68gold quality
lower esophagus muscularis layerUBERON:003583367.67gold quality
body of uterusUBERON:000985367.59gold quality
islet of LangerhansUBERON:000000667.58gold quality
neocortexUBERON:000195067.51gold quality
popliteal arteryUBERON:000225067.48gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.67

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): STAT1

miRNA regulators (miRDB)

52 targeting ZNF425, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4510100.0066.602050
HSA-MIR-6127100.0066.762188
HSA-MIR-6129100.0066.462080
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-6744-5P99.9366.82748
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-430299.8967.941187
HSA-MIR-612499.8769.783551
HSA-MIR-374C-5P99.8072.062910
HSA-MIR-655-3P99.8072.192909
HSA-MIR-202-5P99.7867.65991
HSA-MIR-807699.7868.521170
HSA-MIR-320A-3P99.7769.732107
HSA-MIR-320B99.7769.732107
HSA-MIR-320C99.7769.732107
HSA-MIR-320D99.7769.732107
HSA-MIR-442999.7769.622111
HSA-MIR-7-5P99.6770.531809
HSA-MIR-426199.5970.303415
HSA-MIR-443799.5265.291266
HSA-MIR-186-3P99.5166.241685
HSA-MIR-147B-5P99.4570.622432
HSA-MIR-442799.3470.331854
HSA-MIR-751599.3168.221795
HSA-MIR-504-3P99.3067.181745

Literature-anchored findings (GeneRIF, showing 1)

  • Over-expression of ZNF425 inhibits the transcriptional activities of SRE, AP-1, and SRF. Deletion analysis indicates that the C2H2 domain is the main region responsible for the repression. (PMID:21266108)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
drosophila_melanogasterCG2712FBGN0024975
drosophila_melanogasterPhsFBGN0036522
drosophila_melanogasterCG3281FBGN0260741

Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300)

Protein

Protein identifiers

Zinc finger protein 425Q6IV72 (reviewed: Q6IV72)

All UniProt accessions (3): A0A090N7U3, Q6IV72, C9JNW7

UniProt curated annotations — full annotation on UniProt →

Function. Acts as a transcriptional repressor.

Subcellular location. Nucleus. Cytoplasm.

Domain organisation. The C2H2 domain is necessary for the transcriptional repression.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (1): NP_001001661* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR003655aKRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050589Ikaros_C2H2-ZFFamily

Pfam: PF00096, PF01352

UniProt features (25 total): zinc finger region 19, sequence conflict 3, chain 1, domain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6IV72-F172.510.03

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway
R-HSA-9843940Regulation of endogenous retroelements by KRAB-ZFP proteins

MSigDB gene sets: 50 (showing top): GSE45365_NK_CELL_VS_CD8_TCELL_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CREB3L4_TARGET_GENES, DLX4_TARGET_GENES, ID1_TARGET_GENES, ID2_TARGET_GENES, NAB2_TARGET_GENES, RBM34_TARGET_GENES, SNIP1_TARGET_GENES, TOP2B_TARGET_GENES, ZNF30_TARGET_GENES, ZNF610_TARGET_GENES

GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of DNA-templated transcription (GO:0045892), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (3): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
RNA Polymerase II Transcription1
Regulation of endogenous retroelements1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription2
DNA-templated transcription2
cellular anatomical structure2
transcription by RNA polymerase II1
negative regulation of RNA biosynthetic process1
regulation of gene expression1
regulation of RNA biosynthetic process1
transcription cis-regulatory region binding1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1
nuclear lumen1
intracellular anatomical structure1

Protein interactions and networks

STRING

316 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF425C7orf33Q8WU49507
ZNF425DRC11LA6NCM1481
ZNF425ZNF280BQ86YH2474
ZNF425ANTXR1Q9H6X2452
ZNF425A0A087WTJ2A0A087WTJ2448
ZNF425OR8B8Q15620448
ZNF425TMBIM6P55061447
ZNF425ZBED10PQ96FA7446
ZNF425WDR86Q86TI4420
ZNF425LRRC61Q9BV99419
ZNF425YPEL3P61236406
ZNF425ACOT13Q9NPJ3398
ZNF425PCMT1P22061397
ZNF425UGGT2Q9NYU1395
ZNF425CEP170Q5SW79387

IntAct

4 interactions, top by confidence:

ABTypeScore
KRTAP10-7ZNF425psi-mi:“MI:0915”(physical association)0.560
ZNF425KRTAP10-7psi-mi:“MI:0915”(physical association)0.560

BioGRID (1): KRTAP10-7 (Two-hybrid)

ESM2 similar proteins: A3KN32, A3KN36, O14709, O43296, O75123, P15622, P16373, P17023, P17031, P17097, P52736, P85977, Q07230, Q12901, Q14929, Q29RZ4, Q4V8A8, Q571J5, Q5CZA5, Q5JNZ3, Q5R7I8, Q5RBX0, Q5RBY9, Q5RCD9, Q5RCX4, Q61751, Q61967, Q6GQR8, Q6IV72, Q6NX45, Q6PK81, Q6ZMS4, Q7TNU6, Q7TSH9, Q7Z398, Q7Z7L9, Q8BI99, Q8BIQ3, Q8BLB0, Q8IZ26

Diamond homologs: A2A761, A6NFI3, A6NK75, A6NM28, A6NP11, A6QPT6, A8MQ14, A8MTY0, A8MUV8, B4DU55, B4DX44, B4DXR9, O60290, O75373, O75437, O95780, P0DPD5, P17014, P17032, P35789, P51523, P52736, P52738, Q02525, Q03923, Q03936, Q05481, Q06730, Q06732, Q14587, Q14593, Q14929, Q15928, Q16587, Q2KI58, Q3B7M4, Q3SXZ3, Q3U133, Q49AA0, Q4R6C2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

105 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance96
Likely benign6
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

520 predictions. Top by Δscore:

VariantEffectΔscore
7:149112294:CC:Cacceptor_gain1.0000
7:149112295:CC:Cacceptor_gain1.0000
7:149118216:TCTTA:Tdonor_loss1.0000
7:149118217:CTTA:Cdonor_loss1.0000
7:149118218:TTACC:Tdonor_loss1.0000
7:149118219:TAC:Tdonor_loss1.0000
7:149118220:A:ACdonor_gain1.0000
7:149118220:AC:Adonor_gain1.0000
7:149118221:C:CCdonor_gain1.0000
7:149118221:C:Gdonor_loss1.0000
7:149118221:CC:Cdonor_gain1.0000
7:149118310:C:CTacceptor_gain1.0000
7:149118310:C:Tacceptor_gain1.0000
7:149118348:CCTG:Cacceptor_loss1.0000
7:149118349:CTG:Cacceptor_loss1.0000
7:149112130:TAC:Tdonor_loss0.9900
7:149112131:A:ACdonor_gain0.9900
7:149112131:AC:Adonor_loss0.9900
7:149112132:C:CCdonor_gain0.9900
7:149112133:TCACC:Tdonor_loss0.9900
7:149112134:CA:Cdonor_loss0.9900
7:149112135:A:ACdonor_gain0.9900
7:149112135:A:Tdonor_loss0.9900
7:149112136:C:CCdonor_gain0.9900
7:149112136:C:CTdonor_loss0.9900
7:149112153:T:Adonor_gain0.9900
7:149112292:TACC:Tacceptor_gain0.9900
7:149118215:ATCTT:Adonor_loss0.9900
7:149118216:T:Cdonor_gain0.9900
7:149118220:ACC:Adonor_gain0.9900

AlphaMissense

5025 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:149103913:A:GL653P0.997
7:149103930:G:CF647L0.997
7:149103930:G:TF647L0.997
7:149103932:A:GF647L0.997
7:149104602:G:CF423L0.997
7:149104602:G:TF423L0.997
7:149104604:A:GF423L0.997
7:149104686:G:CF395L0.997
7:149104686:G:TF395L0.997
7:149104688:A:GF395L0.997
7:149104770:G:CF367L0.997
7:149104770:G:TF367L0.997
7:149104772:A:GF367L0.997
7:149103678:G:CF731L0.996
7:149103678:G:TF731L0.996
7:149103680:A:GF731L0.996
7:149103903:G:CH656Q0.996
7:149103903:G:TH656Q0.996
7:149104014:G:CF619L0.996
7:149104014:G:TF619L0.996
7:149104016:A:GF619L0.996
7:149104266:G:CF535L0.996
7:149104266:G:TF535L0.996
7:149104268:A:GF535L0.996
7:149104323:G:CH516Q0.996
7:149104323:G:TH516Q0.996
7:149104350:A:CF507L0.996
7:149104350:A:TF507L0.996
7:149104352:A:GF507L0.996
7:149104182:G:CF563L0.995

dbSNP variants (sampled 300 via entrez): RS1000049038 (7:149125009 A>C), RS1000103298 (7:149122653 G>A), RS1000177579 (7:149109983 T>A,C), RS1000398837 (7:149125310 G>A), RS1001074488 (7:149106740 G>A), RS1001141235 (7:149112580 T>A), RS1001201127 (7:149104968 C>G,T), RS1001242820 (7:149108206 C>T), RS1001413335 (7:149102627 C>G,T), RS1001419438 (7:149110956 G>A), RS1001546049 (7:149117387 G>A), RS1001590807 (7:149108483 C>T), RS1001830286 (7:149123663 T>C), RS1001935328 (7:149116313 G>A), RS1002176463 (7:149123328 A>G,T)

Disease associations

OMIM: gene MIM:619507 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

28 total (human), top 28 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
afuresertibincreases expression1
sodium arseniteincreases expression1
zinc chromateincreases abundance, increases expression1
ferrous chloridedecreases expression1
chromium hexavalent ionincreases abundance, increases expression1
nutlin 3affects cotreatment, increases expression1
ICG 001increases expression1
abrineincreases expression1
NSC668394increases expression1
Sunitinibincreases expression1
Acetaminophenincreases expression1
Ethanolincreases expression1
Benzo(a)pyreneincreases expression1
Camptothecinincreases expression1
Dactinomycinaffects cotreatment, increases expression1
Dichlorodiphenyl Dichloroethylenedecreases expression1
Silicon Dioxidedecreases expression1
Smokedecreases expression1
Tobacco Smoke Pollutionincreases expression1
Urethaneincreases expression1
Valproic Acidincreases methylation1
Aflatoxin B1increases expression1
Asbestos, Crocidolitedecreases expression1
Palmitic Acidincreases expression1
Okadaic Aciddecreases expression1
Lactic Aciddecreases expression1
Acrylamideincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.